相关实验视频

Updated: Jul 5, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

作为一个预后生物标志物和潜在的免疫治疗点在男性状甲状腺癌的TIPARP

Jianlin Zhang¹, Xumin Zhou¹, Fan Yao¹

¹General Surgery Center, Department of Thyroid Surgery, Zhujiang Hospital, Southern Medical University, 253 Gongye Middle Avenue, Haizhu District, Guangzhou, Guangdong, 510280, China.

Cancer cell international

|January 17, 2024

概括

一个新的11个基因的签名和名谱准确地预测了男性乳头甲状腺癌 (PTC) 患者的淋巴结转移,提供了对性别差异和TIPARP等潜在治疗点的见解.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
分子生物学分子生物学

背景情况:

男性乳头甲状腺癌 (PTC) 患者的预后较差,与较高的淋巴结转移率 (LNM) 有关.
现有的男性PTC中LNM的预测模型需要提高准确性.
在男性PTC中开发LNM的精确预后模型至关重要.

研究的目的:

为了确定一个强大的基因特征来预测男性PTC患者的LNM.
开发一个预后名录,用于男性PTC的风险分层.
探索TIPARP在性别特异性PTC结果中的作用.

主要方法:

对公共微阵列数据集的分析,以确定男性PTC中差异表达的基因.
使用单变Cox和拉索回归构建11个基因特征.
使用TCGA数据验证TIPARP表达和开发一个名ogram.

主要成果:

这种11个基因的特征显示出对LNM预测具有强大的区分能力.
高TIPARP表达与高级阶段,T阶段和LNM相关.
预后名录有效地将患者分为高复发风险组和低复发风险组.

结论:

一个11基因签名和名图可靠地预测男性PTC中的LNM.
TIPARP是一种潜在的生物标志物和治疗点,有助于男性PTC结果.
这项研究阐明了PTC性别差异背后的分子机制.

关键词:

豁免权是一种豁免权.淋巴结转移是淋巴结的转移.乳头甲状腺癌是一种乳头甲状腺癌.性差异性差异性差异性差异性差异性差异性差异性差异性差异性差异性

更多相关视频

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.